» Articles » PMID: 8291509

Chenodeoxycholate: the Bile Acid. The Drug. a Review

Overview
Journal Am J Med Sci
Publisher Elsevier
Specialty General Medicine
Date 1994 Jan 1
PMID 8291509
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Chenodeoxycholate (3 alpha, 7 alpha-dihydroxy-5 beta-cholanic acid) is a primary bile acid directly synthesized from cholesterol. It is an amphipathic molecule, possessing both a hydrophobic side and a polar hydrophilic side, giving it the ability to solubilize lipids in a water environment. Bile acids are necessary for the absorption of fats and fat soluble vitamins. Chenodeoxycholate inhibits the rate-limiting step of cholesterol synthesis, the formation of hydroxymethyl-glutaryl-coenzyme A. It was first reported to be useful in the dissolution of cholesterol gallstones in 1972. Today, chenodeoxycholate has other medicinal uses and is used for the management of cerebrotendinous xanthomatosis, hypertriglyceremia, congenital liver diseases, rheumatoid arthritis, and constipation. This article details some finer points of chenodeoxycholate biochemistry and physiology and discusses in some detail the current and past clinical uses of chenodeoxycholate. This is not an exhaustive discussion on gallstone dissolution therapies, but an overview of some of the lesser-known uses for this drug.

Citing Articles

An overview of recent treatment options for primary sclerosing cholangitis.

Mousavere I, Kalampokis G, Fousekis F, Karayiannis P, Baltayiannis G, Christodoulou D Ann Gastroenterol. 2023; 36(6):589-598.

PMID: 38023975 PMC: 10662072. DOI: 10.20524/aog.2023.0834.


Effects of Fat Type and Exogenous Bile Acids on Growth Performance, Nutrient Digestibility, Lipid Metabolism and Breast Muscle Fatty Acid Composition in Broiler Chickens.

Geng S, Zhang Y, Cao A, Liu Y, Di Y, Li J Animals (Basel). 2022; 12(10).

PMID: 35625104 PMC: 9137457. DOI: 10.3390/ani12101258.


Biguanide Pharmaceutical Formulations and the Applications of Bile Acid-Based Nano Delivery in Chronic Medical Conditions.

Jones M, Ionescu C, Walker D, Wagle S, Kovacevic B, Chester J Int J Mol Sci. 2022; 23(2).

PMID: 35055022 PMC: 8775521. DOI: 10.3390/ijms23020836.


An update on treatment options for primary sclerosing cholangitis.

Iravani S, Dooghaie-Moghadam A, Razavi-Khorasani N, Moazzami B, Beirami A, Mansour-Ghanaei A Gastroenterol Hepatol Bed Bench. 2020; 13(2):115-124.

PMID: 32308932 PMC: 7149806.


Therapeutic Effect of Chenodeoxycholic Acid in an Experimental Rabbit Model of Osteoarthritis.

Yan Z, Dong J, Qin C, Zhao C, Miao L, He C Mediators Inflamm. 2015; 2015:780149.

PMID: 26538834 PMC: 4619964. DOI: 10.1155/2015/780149.